Daytime TV star Susan Lucci and husband Helmut Huber discuss living with atrial fibrillation with StopAfib.org founder Mellanie True Hills in a new video released as part of the Facing AFib™ program to encourage getting serious about atrial fibrillation and stroke.
Breaking News: Rivaroxaban As Good as Warfarin for Atrial Fibrillation Stroke Prevention
In late breaking clinical trials presented today at the American Heart Association Scientific Sessions, results of the ROCKET AF trial indicated that in an atrial fibrillation patient population that was at a very high risk of stroke, rivaroxaban (Xarelto) was as good as warfarin at preventing strokes. Learn more at: Rivaroxaban comparable to warfarin in [...]
Canada Approves PRADAX (Dabigatran) for Atrial Fibrillation (Afib) Stroke Prevention
On the heels of the US FDA approving dabigatran, the long-awaited alternative to Coumadin (warfarin), comes word that Health Canada has as well. In Canada, dabigatran is known as PRADAX™. Because this is the first alternative to warfarin in Canada, it is big news for the afib community there. Learn more at: Health Canada Approves [...]
Pradaxa (dabigatran) approved as alternative to warfarin for reducing atrial fibrillation stroke risk
The long-awaited alternative to Coumadin (warfarin) has just been approved by the US FDA. The FDA just approved Pradaxa (dabigatran) for use by those with atrial fibrillation for preventing afib-related strokes. The FDA based approval on results of the RE-LY trial, which saw patients on Pradaxa having fewer strokes than those on warfarin. And Pradaxa [...]
Breaking News: FDA Panel Unanimously Recommends Approval of Dabigatran to Decrease Stroke Risk in Atrial Fibrillation
An FDA panel today unanimously recommended that the FDA approve dabigatran (Pradaxa) for reducing the risk of afib strokes. FDA approval is expected quickly, making this the first alternative to warfarin approved in the United States, and also the first atrial fibrillation approval for dabigatran. It is approved in over 70 countries for venous thromboembolisms [...]
If Catheter Ablation Reduces Alzheimer’s Disease and Stroke Risk Then Keeping Atrial Fibrillation Patients in Sinus Rhythm May Become the Goal
Findings presented at Heart Rhythm 2010 showed that stopping atrial fibrillation—whether through medication, surgery, or in the case of this study, catheter ablation— could potentially prevent the risk of developing Alzheimer’s disease and other dementias and also reduce the risk of stroke and death. Doctors John D. Day, MD, and T. Jared Bunch, MD, at [...]
What is Success for Atrial Fibrillation Catheter Ablation — Report from Heart Rhythm Society 2010
An important session at Heart Rhythm Society 2010 was “Medical Issues After Ablation for Atrial Fibrillation and Flutter.” It dealt with what constitutes success following catheter ablation for atrial fibrillation (afib) and atrial flutter, and which is more important, the medical definition or the patient’s definition. Which definition is used can have implications for treatment [...]
Dr. Nassir Marrouche Discusses Use of MRI to Personalize Atrial Fibrillation Treatment and Avoid Stroke – Video
In this video interview, Dr. Nassir Marrouche, Executive Director of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System, discusses the findings he recently presented at the Heart Rhythm Society annual meeting in Denver. He discussed the intriguing way they are using MRI (magnetic resonance imaging), to personalize atrial [...]
Use of MRI to Personalize Atrial Fibrillation Treatment and Avoid Stroke – Presentation by Dr. Nassir Marrouche at HRS
At Heart Rhythm Society 2010, we saw intriguing new research into personalized afib treatment and stroke prevention that was presented by Dr. Nassir Marrouche and Dr. Marcos Daccarett of the Comprehensive Arrhythmia Research and Management (CARMA) Center at the University of Utah Health System. They have developed a way, using MRI (magnetic resonance imaging), to [...]
